Yutaka Muto
About
In The Last Decade
Yutaka Muto
24 papers receiving 284 citations
Peers
Comparison fields: 5 of 67
- Pulmonary and Respiratory Medicine 94
- Clinical Psychology 87
- Infectious Diseases 69
- General Health Professions 65
- Neurology 48
Countries citing papers authored by Yutaka Muto
This map shows the geographic impact of Yutaka Muto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Muto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Muto more than expected).
Fields of papers citing papers by Yutaka Muto
This network shows the impact of papers produced by Yutaka Muto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Muto. The network helps show where Yutaka Muto may publish in the future.
Co-authorship network of co-authors of Yutaka Muto
This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Muto. A scholar is included among the top collaborators of Yutaka Muto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Muto. Yutaka Muto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 21 | |
| 8 | 3 | |
| 9 | 23 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 14 | |
| 13 | 38 | |
| 14 | 12 | |
| 15 | 11 | |
| 16 | 16 | |
| 17 | 96 | |
| 18 | 7 | |
| 19 | [Flow cytometric determination of active oxygen produced by neutrophils in patients with inflammatory diseases]. | 1 |
| 20 | Effect of oral supplementation with BCAA-G on the prognosis of liver cirrhosis | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.